Centre must pay for treatment of underprivileged Covid patients: Mayawati

Topics Mayawati | BSP

Bahujan Samaj Party supremo Mayawati

Bahujan Samaj Party (BSP) supremo Mayawati on Monday demanded that the Centre should bear the expenses of treatment of COVID-19 patients from the poor and the weaker sections, and administer free vaccines to all.

If the Centre refuses to accept this, state governments must take up the responsibility themselves by cutting down on non-essential expenditure, she said.

"Rising above party politics, all parties should demand that the central government bear all expenses for the treatment of COVID-19-affected poor and weaker section people and administer the vaccine free of cost," Mayawati said in a series of tweets in Hindi.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel